Hematology:
Changes in WBCs, RBCs, Hb, hematocrit, MCV, platelets, neutrophils,
eosinophils, monocytes and lymphocytes were evaluated. Induction of
alloxan increased in WBCs, hematocrit, platelets and neutrophils and
decreased in RBCs, Hb, MCV and lymphocytes significantly. Treatment with
BLR extract and glibenclamide revesed most of these changes
significantly. All other changes were non-significant (figure 8a
and 8b